Hemlibra (emicizumab) is a brand-name drug that’s prescribed to prevent bleeding episodes due to hemophilia A in adults and children. Hemlibra comes as a subcutaneous injection that’s given once per ...

Hemlibra is a once-weekly injection for patients with hemophilia A who have developed a resistance to other treatments. The drug’s label contains a black box warning over the risk of severe blood ...

Medically reviewed by Doru Paul, MD Key Takeaways Hemophilia A is a bleeding disorder caused by a deficiency in factor VIII. Treatment options for hemophilia A include replacing factor VIII and gene ...